There are a number of ways in which U.S. manufacturers that believe they are being harmed by imports can seek protection. An increasingly popular tool to consider is filing a Section 337 proceeding at the International Trade Commission.

The Federal Circuit decision in Cleveland Clinic Foundation v. True Health Diagnostics LLC, strikes another blow against the patent eligibility of diagnostic methods and highlights the difficulty of enforcing personalized medicine patents.

Indiana has taken another step towards expanding the meaningful use of telemedicine in connection with clinical services and prescribing.

As a life sciences or medical device company, it is mission critical to protect lab books, drug and clinical test data, product formulas and production processes that underlie your patents, trade secrets and know-how from hackers and others.

Foley’s Automotive Industry Team has prepared this report that examines what the litigation, enforcement, and regulatory landscape will look like in 2017.

Last June, we held our 11th CEO/Innovators Roundtable in Boston. This two-day gathering brought together some of the most dynamic minds in health care to share ideas, examine new opportunities, and debate solutions for improving quality of care and containing costs. As in the past, the group consisted of leaders of health systems, health plans, and medical groups, as well as legal experts, health care entrepreneurs, and investors.